Financhill
Back

Myriad Genetics Quote, Financials, Valuation and Earnings

Myriad Genetics Price Quote

$15.14
-0.16 (-1.05%)
(Updated: November 21, 2024 at 2:30 PM ET)

Myriad Genetics Key Stats

Sell
16
Myriad Genetics (MYGN) is a Sell

Day range:
$14.72 - $15.33
52-week range:
$14.91 - $29.30
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.65
P/B ratio:
1.89%

Volume:
687.1K
Avg. volume:
914.4K
1-year change:
-15.28%
Market cap:
$1.4B
Revenue:
$753.2M
EPS:
$-1.3

How Much Does Myriad Genetics Make?

Is Myriad Genetics Growing As A Company?

  • What Is Myriad Genetics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.11%
  • What Is Myriad Genetics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Myriad Genetics Stock Price Performance

  • Did Myriad Genetics Stock Go Up Last Month?
    Myriad Genetics share price went down by -34.59% last month
  • Did MYGN's Share Price Rise Over The Last Year?
    MYGN share price fell by -15.28% over the past 1 year

What Is Myriad Genetics 52-Week High & Low?

Myriad Genetics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Myriad Genetics?

  • How Much Debt Does Myriad Genetics Have?
    Total long term debt quarterly is $39M
  • How Much Cash Does Myriad Genetics Have?
    Cash and short term investments quarterly total is $99.9M
  • What Is Myriad Genetics’s Book Value Per Share?
    Book value per share is 8.04

Is Myriad Genetics Cash Flow Positive?

  • What Is MYGN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$70M
  • What Is Myriad Genetics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $112.4M
  • What Is Myriad Genetics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$18M

Myriad Genetics Return On Invested Capital

  • Is Management Doing A Good Job?
    MYGN return on invested capital is -14.9%
  • What Is Myriad Genetics Return On Assets?
    ROA measures how assets are converting to revenues and is -10.41%
  • What Is MYGN Return On Equity?
    ROE is a measure of profitability and is -15.68%

Myriad Genetics Earnings Date & Stock Price

Myriad Genetics Competitors

  • Who Are Myriad Genetics's Competitors?
    Below is a list of companies who compete with Myriad Genetics or are related in some way:
    • Boston Scientific Corp (BSX)
    • Perspective Therapeutics Inc (CATX)
    • Electromed Inc (ELMD)
    • Globus Medical Inc (GMED)
    • ResMed Inc (RMD)

Myriad Genetics Dividend Yield

Myriad Genetics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 211.04%
Revenue: 11.15% 1.19%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 4
Sell Recommendations: 1
Price Target: 24.08
Upside from Last Price: 57.37%

Major Shareholders

  • How many MYGN shares are owned by institutional investors?
    150.9M MYGN shares are owned by institutional investors
  • How many MYGN shares are owned by insiders?
    6.9M MYGN shares are owned by insiders